Download the list of NSQ samples for April 2022 given below: The Central Drugs Standard Control Organisation (CDSCO) has declared 27 drug samples out of a total of 1164 drug samples tested as not of standard quality (NSQ) & none declared as misbranded during the month of April, 2022. Click here to download NSQ list April 2022 Out of the 1164 samples tested during the month, 1137 samples came out with standard quality, while 27 samples declared as not of standard quality (NSQ) & none declared as misbranded. Picture: Pixabay None of the samples were identified as spurious and adulterated during the month. Every month, the drug regulator comes up with a list of drugs, medical devices and cosmetics that are declared not of standard quality / spurious / adulterated, or misbranded, every month. Click to download month and year wise lists of NSQ drugs During the month of March, 2022, the authorities tested 1454 samples, out of which 1406 samples were tested as of standard quality. The number of samples declared as not of standard quality was 48 and none as misbranded. During the month of February, 2022, the authorities tested 1221 samples, out of which 1181 samples were tested as of standard quality. The number of samples declared as not of standard quality was 39 and one as misbranded. During the month of January, 2022, the authorities tested 1227 samples, out of which 1200 samples were tested as of standard quality. The number of samples declared as not of standard quality was 27 and none as misbranded. During the month of December, 2021, the authorities tested 1385 samples, out of which 1350 samples were tested as of standard quality. The number of samples declared as not of standard quality was 33 and 2 as misbranded. During the month of November, 2021, the authorities tested 1102 samples, out of which 1080 samples were tested as of standard quality. The number of samples declared as not of standard quality was 22 and none as misbranded. During the month of October, 2021, the authorities tested 1061 samples, out of which 1025 samples were tested as of standard quality. The number of samples declared as not of standard quality was 36 and none as misbranded. During the month of September, 2021, the authorities tested 1227 samples, out of which 1184 samples were tested as of standard quality. The number of samples declared as not of standard quality was 42 and one as misbranded. The test samples were drawn by the zonal and sub zonal offices of CDSCO, and tested in the drug testing laboratories in Kolkata, Mumbai, Hyderabad, Chandigarh, and Guwahati. Month wise drug alerts Drug alert: 48 out of 1454 samples declared as NSQ in March 2022 Drug alert: 40 out of 1221 samples declared as NSQ in February 2022 Drug alert: 27 out of 1227 samples declared as NSQ in January 2022 Drug alert: 33 out of 1385 samples declared as NSQ in December 2021 Drug alert: 22 out of 1102 samples declared as NSQ in November 2021 Drug alert: 36 out of 1061 samples declared as NSQ in October 2021 Drug alert: 42 out of 1227 samples declared as NSQ in September 2021 Drug alert: 38 out of 1245 samples declared as NSQ in August 2021 Drug alert: 44 out of 1028 samples declared as NSQ in July 2021 Drug alert: 39 out of 681 samples declared as NSQ in June 2021 Commercial Testing Laboratories Govt Laboratories List of Laboratory instruments Latest Notifications: Testing Laboratories FAQs – on Schedule-P (Expiry Date of drugs) USFDA gives nod to Sun Pharma Mesalamine extended release capsules NPPA refuses to exempt these drugs from DPCO 2013 USFDA gives approval to Alembic Pharma for Arformoterol Tartrate Inhalation Solution High court orders removal of all Pharmacy Council members NPPA fixes Retail Price of 84 formulations: May 2022 NPPA fixes retail price of Emcure’s HIV drug combination USFDA gives nod to Alembic for this generic solution for Inhalation USFDA gives 10 observations to Sun Pharm Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/05/14/drug-alert-27-out-of-1164-samples-declared-as-nsq-in-april-2022/